#PrecisionTimedRelease

John Vandermosten

@vanjohn10.bsky.social

3 weeks ago

Step Edits for CTx1301 YouTube video by Unboxing Biotech

Cingulate Inc.’s SVP of Market Access Rick Arce discusses the role of step edits and prior authorizations for CTx-1301. $CING #PrecisionTimedRelease #PTR #Biotech #FDA #PDUFA #NDA youtube.com/shorts/n0xtr...

John Vandermosten

@vanjohn10.bsky.social

3 weeks ago

Cingulate CEO Shane Schaffer talks about the financing environment for small cap life sciences companies & its recent raise. $CING
#PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #DrugDelivery #ExtendedRelease #ControlledRelease
youtube.com/shorts/CZ-Cn...

John Vandermosten

@vanjohn10.bsky.social

3 weeks ago

Sales Strategy YouTube video by Unboxing Biotech

EVP and Chief Commercial Officer Bryan Downey describes Cingulate’s sales and marketing strategy for CTx-1301. $CING #CTx-1301 #ADHD #PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #DrugDelivery #ExtendedRelease #ControlledRelease
youtube.com/shorts/sVbvZ...

John Vandermosten

@vanjohn10.bsky.social

1 month ago

Payors and CTx1301 YouTube video by Unboxing Biotech

Cingulate’s SVP of Market Access Rick Arce makes the case for CTx-1301 to payors we move towards the May 31 2026 target action date.
$CING
#PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #DrugDelivery
youtube.com/shorts/aKWRi...

John Vandermosten

@vanjohn10.bsky.social

1 month ago

Indigene's Commercialization Role YouTube video by Unboxing Biotech

EVP and Chief Commercial Officer Bryan Downey explains Indegene’s role in Cingulate’s commercialization efforts for CTx-1301 in ADHD. $CING
#PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #ControlledRelease #Dexmethylphenidate
youtube.com/shorts/UnnYM...

John Vandermosten

@vanjohn10.bsky.social

1 month ago

Market Access and Strategy YouTube video by Unboxing Biotech

As we advance to CTx-1301’s 31May26 target action date, Cingulate SVP of Market Access Rick Arce explains the process of getting payors on board. $CING
#PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #DrugDelivery #Dexmethylphenidate
youtube.com/shorts/T-fYV...

John Vandermosten

@vanjohn10.bsky.social

1 month ago

Benefits of Cingulate CTx 1301 YouTube video by Unboxing Biotech

As we move towards CTx-1301’s 31May26 target action date, Cingulate CEO Shane Schaffer describes payors reactions to the medicine. $CING
#PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #PDUFA #NDAFails
youtube.com/shorts/nIzin...